Low‐dose i.v. urokinase for coronary thrombosis in Kawasaki disease
Low‐dose i.v. urokinase for coronary thrombosis in Kawasaki disease
复制标题
低剂量静脉注射尿激酶治疗川崎病冠状动脉血栓
DOI：
10.1111/ped.13783
复制
发表时间：
2019
影响因子：
1.4
通讯作者：
Kato Yoshiaki
中科院分区：
文献类型：
--
作者：
Serizawa Haruna;Lin Lisheng;Sato Takuro;Takahashi‐Igari Miho;Kato Yoshiaki
一个2岁的男孩的病例研究，谁是承认，因为发烧的第一天的疾病，嘴唇发红，颈部淋巴结肿大，皮疹，结膜炎，硬化水肿的四肢随后在第三和第四天。本文讨论了川崎后冠状动脉瘤（CAA）的血栓形成。经小剂量尿激酶静脉溶栓治疗后病情好转。
A case study of a 2-year-old boy is presented who was admitted because of fever on the first day of illness, and lip redness, cervical lymphadenopathy, skin rash, conjunctivitis, indurated edema of extremities followed on third and fourth days. The article discusses thrombosis of coronary artery aneurysm (CAA) after the occurrence of Kawasaki disease (KD). It is notes that the patient's conditions were improved after intravenous therapy coronary thrombolysis with low-dose urokinase.